Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an ...

This year, drug companies have been living under a cloud of uncertainty created by the Trump administration. Threats of tough ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

Amgen is dealing with the threat of several fast-approaching patent expirations. The drugmaker's dividend streak is ...